Literature DB >> 33370229

AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.

Paolo Caraceni1, Paolo Angeli2, Daniele Prati3, Mauro Bernardi1, Pierluigi Berti4, Francesco Bennardello5, Francesco Fiorin6, Pierluigi Piccoli7.   

Abstract

Entities:  

Year:  2020        PMID： 33370229      PMCID： PMC7850931          DOI： 10.2450/2020.0414-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  27 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  Appropriateness of requests for human serum albumin at the University Hospital of Palermo, Italy: a prospective study.

Authors:  Alessandra Casuccio; Eliana Nalbone; Palmira Immordino; Concetta La Seta; Paola Sanfilippo; Antonino Tuttolomondo; Francesco Vitale
Journal:  Int J Qual Health Care       Date:  2015-02-10       Impact factor: 2.038

3.  Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

4.  Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

Authors:  Elsa Solà; Cristina Solé; Macarena Simón-Talero; Marta Martín-Llahí; José Castellote; Rita Garcia-Martínez; Rebeca Moreira; Maria Torrens; Francisca Márquez; Núria Fabrellas; Gloria de Prada; Patrícia Huelin; Eva Lopez Benaiges; Meritxell Ventura; Marcela Manríquez; André Nazar; Xavier Ariza; Pilar Suñé; Isabel Graupera; Elisa Pose; Jordi Colmenero; Marco Pavesi; Mónica Guevara; Miquel Navasa; Xavier Xiol; Joan Córdoba; Victor Vargas; Pere Ginès
Journal:  J Hepatol       Date:  2018-08-21       Impact factor: 25.083

5.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2018-04-10       Impact factor: 25.083

Review 6.  Novel perspectives in the management of decompensated cirrhosis.

Authors:  Mauro Bernardi; Paolo Caraceni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 7.  The Therapeutic use of human albumin in cancer patients' management.

Authors:  Elissar Moujaess; May Fakhoury; Tarek Assi; Hanine Elias; Fadi El Karak; Marwan Ghosn; Joseph Kattan
Journal:  Crit Rev Oncol Hematol       Date:  2017-11-20       Impact factor: 6.312

8.  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Authors:  Paolo Caraceni; Oliviero Riggio; Paolo Angeli; Carlo Alessandria; Sergio Neri; Francesco G Foschi; Fabio Levantesi; Aldo Airoldi; Sergio Boccia; Gianluca Svegliati-Baroni; Stefano Fagiuoli; Roberto G Romanelli; Raffaele Cozzolongo; Vito Di Marco; Vincenzo Sangiovanni; Filomena Morisco; Pierluigi Toniutto; Annalisa Tortora; Rosanna De Marco; Mario Angelico; Irene Cacciola; Gianfranco Elia; Alessandro Federico; Sara Massironi; Riccardo Guarisco; Alessandra Galioto; Giorgio Ballardini; Maria Rendina; Silvia Nardelli; Salvatore Piano; Chiara Elia; Loredana Prestianni; Federica Mirici Cappa; Lucia Cesarini; Loredana Simone; Chiara Pasquale; Marta Cavallin; Alida Andrealli; Federica Fidone; Matteo Ruggeri; Andrea Roncadori; Maurizio Baldassarre; Manuel Tufoni; Giacomo Zaccherini; Mauro Bernardi
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

9.  The evaluation of albumin utilization in a teaching university hospital in iran.

Authors:  Zahra Jahangard-Rafsanjani; Mohammad Reza Javadi; Hassan Torkamandi; Sara Alahyari; Azita Hajhossein Talasaz; Kheirollah Gholami
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

10.  On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.

Authors:  Paolo Caraceni; Manuel Tufoni; Giacomo Zaccherini; Oliviero Riggio; Paolo Angeli; Carlo Alessandria; Sergio Neri; Francesco G Foschi; Fabio Levantesi; Aldo Airoldi; Loredana Simone; Gianluca Svegliati-Baroni; Stefano Fagiuoli; Giacomo Laffi; Raffaele Cozzolongo; Vito Di Marco; Vincenzo Sangiovanni; Filomena Morisco; Pierluigi Toniutto; Antonio Gasbarrini; Rosanna De Marco; Salvatore Piano; Silvia Nardelli; Chiara Elia; Andrea Roncadori; Maurizio Baldassarre; Mauro Bernardi
Journal:  J Hepatol       Date:  2020-08-24       Impact factor: 25.083
View more
  3 in total

1.  Update on the Evaluation and Management of Portal Hypertension.

Authors:  Gabriella Aitcheson; Carensa Cezar; Irene John; Binu V John
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

2.  Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications.

Authors:  Maurizio Baldassarre; Marina Naldi; Mauro Bernardi; Paolo Caraceni; Giacomo Zaccherini; Michele Bartoletti; Agnese Antognoli; Maristella Laggetta; Martina Gagliardi; Manuel Tufoni; Marco Domenicali; Katja Waterstradt; Paola Paterini; Anna Baldan; Simona Leoni; Manuela Bartolini; Pierluigi Viale; Franco Trevisani
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425

3.  Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Zhaohui Bai; Le Wang; Hanyang Lin; Frank Tacke; Gang Cheng; Xingshun Qi
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.